v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:            
Research and development $ 21,549 $ 22,952 $ 37,281 $ 44,078 $ 86,113 $ 73,187
General and administrative 4,591 5,307 9,139 10,784 19,554 18,068
Total operating expenses 26,140 28,259 46,420 54,862 105,667 91,255
Loss from operations (26,140) (28,259) (46,420) (54,862) (105,667) (91,255)
Other income, net:            
Interest and other income 276 1,363 923 2,980 5,060 8,146
Total other income 276 1,363 923 2,980 5,060 8,146
Loss before income tax expense (25,864) (26,896) (45,497) (51,882) (100,607) (83,109)
Income tax benefit (expense) 0 0 0 0 0 0
Net loss (25,864) (26,896) (45,497) (51,882) (100,607) (83,109)
Other comprehensive income (loss):            
Unrealized gain (loss) on marketable securities 2 (11) (26) (11) 50 (54)
Total other comprehensive income (loss) 2 (11) (26) (11) 50 (54)
Total comprehensive loss $ (25,862) $ (26,907) $ (45,523) $ (51,893) $ (100,557) $ (83,163)
Net loss per share attributable to common stockholders - Basic $ (1.19) $ (1.93) $ (2.3) $ (3.72) $ (7.22) $ (6.47)
Net loss per share attributable to common stockholders - Diluted $ (1.19) $ (1.93) $ (2.3) $ (3.72) $ (7.22) $ (6.47)
Weighted-average common shares outstanding - Basic 21,808,064 13,939,366 19,751,933 13,931,419 13,935,769 12,848,484
Weighted-average common shares outstanding - Diluted 21,808,064 13,939,366 19,751,933 13,931,419 13,935,769 12,848,484